- Home
- BFIN vs MOLN Comparison
BFIN vs MOLN Comparison
Compare BFIN & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFIN
- MOLN
- Stock Information
- Founded
- BFIN 1924
- MOLN 2004
- Country
- BFIN United States
- MOLN Switzerland
- Employees
- BFIN N/A
- MOLN N/A
- Industry
- BFIN Savings Institutions
- MOLN
- Sector
- BFIN Finance
- MOLN
- Exchange
- BFIN Nasdaq
- MOLN Nasdaq
- Market Cap
- BFIN 145.5M
- MOLN 142.6M
- IPO Year
- BFIN N/A
- MOLN 2021
- Fundamental
- Price
- BFIN $12.14
- MOLN $3.64
- Analyst Decision
- BFIN Hold
- MOLN Hold
- Analyst Count
- BFIN 1
- MOLN 1
- Target Price
- BFIN $11.50
- MOLN $4.00
- AVG Volume (30 Days)
- BFIN 90.6K
- MOLN 5.1K
- Earning Date
- BFIN 11-04-2025
- MOLN 11-05-2025
- Dividend Yield
- BFIN 3.31%
- MOLN N/A
- EPS Growth
- BFIN N/A
- MOLN N/A
- EPS
- BFIN 0.16
- MOLN N/A
- Revenue
- BFIN $45,545,000.00
- MOLN $856,302.00
- Revenue This Year
- BFIN N/A
- MOLN N/A
- Revenue Next Year
- BFIN $6.40
- MOLN $1,000.00
- P/E Ratio
- BFIN $77.22
- MOLN N/A
- Revenue Growth
- BFIN N/A
- MOLN N/A
- 52 Week Low
- BFIN $10.69
- MOLN $3.36
- 52 Week High
- BFIN $13.97
- MOLN $7.60
- Technical
- Relative Strength Index (RSI)
- BFIN 51.76
- MOLN 48.03
- Support Level
- BFIN $11.88
- MOLN $3.69
- Resistance Level
- BFIN $12.45
- MOLN $3.79
- Average True Range (ATR)
- BFIN 0.24
- MOLN 0.13
- MACD
- BFIN -0.06
- MOLN 0.00
- Stochastic Oscillator
- BFIN 30.23
- MOLN 18.18
About BFIN BankFinancial Corporation
BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.